期刊文献+

赖氨酸特异性脱甲基酶2B及B细胞淋巴瘤-2蛋白、Hrk蛋白在卵巢癌组织中的表达情况及其临床意义 被引量:2

Expression and clinical significance of lysine (K)-specific demethylase 2B,B-cell lymphoma-2 protein,and Hrk protein in ovarian cancer tissues
暂未订购
导出
摘要 目的 分析赖氨酸特异性脱甲基酶2B(KDM2B)、B细胞淋巴瘤-2(Bcl-2)蛋白、Hrk蛋白在卵巢癌中的表达情况及其临床意义。方法 收集20例正常卵巢组织、30例良性卵巢肿瘤组织以及50例恶性卵巢肿瘤组织。采用免疫组织化学法检测3种组织KDM2B、Bcl-2蛋白、Hrk蛋白的表达情况。比较不同临床病理特征的恶性卵巢肿瘤患者间3种蛋白表达的情况,并分析恶性卵巢肿瘤组织中3种蛋白表达的相关性。结果 恶性卵巢肿瘤组织的KDM2B、Bcl-2蛋白阳性表达率高于良性卵巢肿瘤组织及正常卵巢组织(均P<0.05),恶性卵巢肿瘤组织、良性卵巢肿瘤组织、正常卵巢组织的Hrk阳性表达率依次升高(均P<0.05)。低分化、国际妇产科联合会(FIGO)分期Ⅲ~Ⅳ期、淋巴结转移病例的KDM2B及Bcl-2蛋白阳性表达率均分别高于中-高分化、FIGO分期Ⅰ~Ⅱ期、无淋巴结转移病例(均P<0.05),而Hrk蛋白阳性表达率均分别低于中-高分化、FIGO分期Ⅰ~Ⅱ期、无淋巴结转移病例(均P<0.05)。不同年龄段病例的3种蛋白阳性表达率比较,差异均无统计学意义(均P>0.05)。在卵巢恶性肿瘤组织中,KDM2B、Bcl-2蛋白与Hrk蛋白的阳性表达率均呈负相关(均P<0.05)。结论 卵巢癌中KDM2B与Bcl-2蛋白的表达上调,Hrk蛋白的表达下调,三者可能通过不同的方式参与卵巢癌的发生发展。 Objective To analyze the expression and clinical significance of lysine(K)-specific demethylase 2B(KDM2B),B-cell lymphoma-2(Bcl-2)protein,and Hrk protein in ovarian cancer tissues.Methods Twenty specimens of normal ovarian tissues,30 specimens of benign ovarian tumor tissues and 50 specimens of malignant ovarian tumor tissues were collected.The expression of KDM2B,Bcl-2 protein and Hrk protein from the three kinds of tissues were detected using immunohistochemistry assay.The expression of the three proteins were compared among patients with malignant ovarian tumors of different clinicopathological features,and the correlation among the three proteins expression in malignant ovarian tumor tissues was analyzed.Results The positive expression rates of KDM2B and Bcl-2 protein in malignant ovarian tumor tissues were higher than those in benign ovarian tumor tissues or normal ovarian tissues(all P<0.05),the positive expression rate of Hrk protein increased in the order of malignant ovarian tumor tissues,benign ovarian tumor tissues,and normal ovarian tissues(all P<0.05).Patients with poor differentiation,with International Federation of Gynecology and Obstetrics(FIGO)stageⅢ-Ⅳ,or with lymphatic metastasis had higher positive expression rates of KDM2B and Bcl-2 protein,along with lower positive expression rate of Hrk protein,than those with moderate-well differentiation,with FIGO stageⅠ-Ⅱ,or without lymphatic metastasis,respectively(all P<0.05).The positive expression rates of the three proteins showed no statistically significant differences among cases of various age groups(all P>0.05).In malignant ovarian tumor tissues,the positive expression rate of KDM2B or Bcl-2 protein negatively correlated with the positive rate of Hrk protein(all P<0.05).Conclusion Up-regulation of KDM2B and Bcl-2 protein,and down-regulation of Hrk protein are observed in ovarian cancer,the three proteins probably participate in the occurrence and development of ovarian cancer via various ways.
作者 易叶叶 况燕 蒙家华 杨慧兰 徐红 侯海瑞 YI Ye-ye;KUANG Yan;MENG Jia-hua;YANG Hui-lan;XU Hong;HOU Hai-rui(Department of Gynecology and Obstetrics,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China)
出处 《广西医学》 CAS 2019年第10期1205-1209,共5页 Guangxi Medical Journal
基金 国家自然科学基金(81360389)
关键词 卵巢癌 赖氨酸特异性脱甲基酶2B B细胞淋巴瘤-2蛋白 Hrk蛋白 Ovarian cancer Lysine(K)-specific demethylase 2B B-cell lymphoma-2 protein Hrk protein
  • 相关文献

参考文献7

二级参考文献61

  • 1王胜军,许化溪,杨胜利.CD4^+CD25^+调节性T细胞[J].细胞生物学杂志,2005,27(1):61-65. 被引量:20
  • 2吕凌,张峰(审校者).介导CD4^+CD25^+调节性T细胞发育与功能的一个关键基因———Foxp3[J].国际免疫学杂志,2006,29(2):65-68. 被引量:8
  • 3孟庆超,王禾,于磊,孟平,王映梅,马福成.Bag-1及Bcl-2在前列腺癌组织中的表达及意义[J].现代肿瘤医学,2007,15(3):366-368. 被引量:9
  • 4Silverberg SG. Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol, 2000, 19( 1 ) : 7-15.
  • 5Singer G, Kurman RJ, Chang HW, et al. Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol, 2002, 160 (4) : 1223-1228.
  • 6Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol, 2004, 28 (4) : 496 -504.
  • 7Shih leM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol, 2004, 164(5) : 1511-1518.
  • 8Tong GX, Chiriboga L, Hamele-Bena D, et al. Expression of PAX2 in papillary serous carcinoma of the ovary : immunohistochemical evidence of fallopian tube or secondary Mtillerian system origin? Mod Pathol, 2007, 20(8) : 856-863.
  • 9O'Neill C J, Deavers MT, Malpica A, et al. An immunohistechemical comparison between low-grade and high- grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, FIER-2/neu, and C-KIT in high-grade neoplasms. Am J Surg Pathol, 2005, 29(8) : 1034-1041.
  • 10Armstrong DK. Relapsed ovarian cancer: challenges and management strategies for a chronic disease. Oncologist, 2002, 7 ( Snppl 5 ) : 20-28.

共引文献37

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部